243 results on '"Holmøy, Trygve"'
Search Results
2. Progressive encephalomyelitis with rigidity and myoclonus (PERM) associated with anti-glycine receptor antibodies and urothelial carcinoma: a case report
3. Tuberculin responses after BCG vaccination predict amyotrophic lateral sclerosis risk
4. Humoral response to Epstein-Barr virus in patients with multiple sclerosis treated with B cell depletion therapy
5. Abuse and revictimization in adulthood in multiple sclerosis: a cross-sectional study during pregnancy
6. Skogholt’s disease—A tauopathy precipitated by iron and copper?
7. Physical Activity, Fitness, and Long-Term Risk of Amyotrophic Lateral Sclerosis: A Prospective Cohort Study.
8. Premorbid lipid levels and long-term risk of ALS—a population-based cohort study.
9. Autologous hematopoietic stem cell transplantation for multiple sclerosis: Long-term follow-up data from Norway.
10. BCG vaccination and multiple sclerosis risk: A Norwegian cohort study.
11. B-cell composition in the blood and cerebrospinal fluid of multiple sclerosis patients treated with dimethyl fumarate
12. «At komme deres værdige og trængende Efterladte til Hjælp».
13. Neurological involvement among non-hospitalized adolescents and young adults 6 months after acute COVID-19.
14. Genetic overlap between ALS and other neurodegenerative or neuromuscular disorders.
15. Prevalence, Risk Factors, and Clinical and Biochemical Characteristics of Alemtuzumab-Induced Graves Disease.
16. Norsk helsevesen bør tilby stamcellebehandling mot multippel sklerose.
17. Ethical challenges in tracheostomy-assisted ventilation in amyotrophic lateral sclerosis
18. A Novel SPAST Variant Associated with Isolated Spastic Paraplegia.
19. CSF, Blood, and MRI Biomarkers in Skogholt's Disease—A Rare Neurodegenerative Disease in a Norwegian Kindred.
20. Serum sickness following rituximab therapy in multiple sclerosis
21. Sex ratio in multiple sclerosis mortality over 65 years; an age-period-cohort analysis in Norway
22. Body mass index influence interferon-beta treatment response in multiple sclerosis
23. En kvinne i 60-årene som ikke lenger gjenkjente det hun så: Kvinnen i denne sykehistorien opplevde symptomer som rokket ved hennes visuelle erkjennelse av verden.
24. Diffuse alveolar hemorrhage during alemtuzumab infusion in a patient with multiple sclerosis: a case report
25. Intrathecal BCR transcriptome in multiple sclerosis versus other neuroinflammation: Equally diverse and compartmentalized, but more mutated, biased and overlapping with the proteome
26. Iron and copper in progressive demyelination – New lessons from Skogholt's disease
27. Vitamin D status and effect of interferon-β1a treatment on MRI activity and serum inflammation markers in relapsing-remitting multiple sclerosis
28. Mortality trends of amyotrophic lateral sclerosis in Norway 1951–2014: an age–period–cohort study
29. Monomethyl fumarate augments NK cell lysis of tumor cells through degranulation and the upregulation of NKp46 and CD107a
30. Vitamin D supplementation and systemic inflammation in relapsing-remitting multiple sclerosis
31. Hereditary motor neuron disease in a large Norwegian family with a “H46R” substitution in the superoxide dismutase 1 gene
32. Vitamin D sensitive EBNA-1 specific T cells in the cerebrospinal fluid of patients with multiple sclerosis
33. Vitamin D in the healthy and inflamed central nervous system: access and function
34. Efficacy of vitamin D3 as add-on therapy in patients with relapsing–remitting multiple sclerosis receiving subcutaneous interferon beta-1a: A Phase II, multicenter, double-blind, randomized, placebo-controlled trial
35. The immunological basis for treatment of stiff person syndrome
36. Humoral immunity to SARS- CoV- 2 mRNA vaccination in multiple sclerosis: the relevance of time since last rituximab infusion and first experience from sporadic revaccinations.
37. The idiotype connection: linking infection and multiple sclerosis
38. Calprotectin levels in the cerebrospinal fluid reflect disease activity in multiple sclerosis
39. Strong tuberculin response after BCG vaccination is associated with low multiple sclerosis risk: a population-based cohort study.
40. The Effect of Smoking on Long-term Gray Matter Atrophy and Clinical Disability in Patients with Relapsing-Remitting Multiple Sclerosis.
41. Serum neurofilament as a predictor of 10-year grey matter atrophy and clinical disability in multiple sclerosis: a longitudinal study.
42. Sex ratio of multiple sclerosis in persons born from 1930 to 1979 and its relation to latitude in Norway
43. Vitamin D status modulates the immune response to Epstein Barr virus: Synergistic effect of risk factors in multiple sclerosis
44. En kvinne i 50-årene med økende gangvansker.
45. Cerebrospinal fluid CD4+ T cells from a multiple sclerosis patient cross-recognize Epstein-Barr virus and myelin basic protein
46. Stereotyped B‐cell responses are linked to IgG constant region polymorphisms in multiple sclerosis.
47. Vitamin D in multiple sclerosis: implications for assessment and treatment
48. Osteoporosis: an under-recognized risk for early-stage multiple sclerosis patients?
49. Association of Body Mass Index in Adolescence and Young Adulthood and Long-term Risk of Multiple Sclerosis: A Population-Based Study.
50. Recent progress in maintenance treatment of neuromyelitis optica spectrum disorder.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.